BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27751355)

  • 1. Mesothelioma families without inheritance of a BAP1 predisposing mutation.
    Ascoli V; Cozzi I; Vatrano S; Izzo S; Giorcelli J; Romeo E; Carnovale-Scalzo C; Grillo LR; Facciolo F; Visca P; Papotti M; Righi L
    Cancer Genet; 2016 Sep; 209(9):381-387. PubMed ID: 27751355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
    Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
    Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
    Betti M; Casalone E; Ferrante D; Romanelli A; Grosso F; Guarrera S; Righi L; Vatrano S; Pelosi G; Libener R; Mirabelli D; Boldorini R; Casadio C; Papotti M; Matullo G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2015 Jan; 54(1):51-62. PubMed ID: 25231345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
    Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR
    Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
    Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma.
    Hylebos M; Op de Beeck K; van den Ende J; Pauwels P; Lammens M; van Meerbeeck JP; Van Camp G
    Fam Cancer; 2018 Oct; 17(4):569-576. PubMed ID: 29961174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
    Sneddon S; Leon JS; Dick IM; Cadby G; Olsen N; Brims F; Allcock RJ; Moses EK; Melton PE; de Klerk N; Musk AW; Robinson BW; Creaney J
    Gene; 2015 May; 563(1):103-5. PubMed ID: 25796603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
    Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
    Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
    Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
    Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H; Yost SE; Woo B; French R; Lin GY; Jepsen K; Frazer KA; Lowy AM; Harismendy O
    J Transl Med; 2015 Apr; 13():122. PubMed ID: 25889843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Histogenetic Analysis Reveals
    Bochtler T; Endris V; Reiling A; Leichsenring J; Schweiger MR; Klein S; Stögbauer F; Goeppert B; Schirmacher P; Krämer A; Stenzinger A
    J Natl Compr Canc Netw; 2018 Jun; 16(6):677-682. PubMed ID: 29891518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puzzling Results from
    Rizzardi C; Athanasakis E; Cammisuli F; Monego SD; DE Spelorzi YCC; Costantinides F; Giudici F; Pinamonti M; Canzonieri V; Melato M; Pascolo L
    Anticancer Res; 2017 Jun; 37(6):3073-3083. PubMed ID: 28551647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant mesothelioma and constitutional BAP1 gene mutations].
    Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
    Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
    Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
    Ribeiro C; Campelos S; Moura CS; Machado JC; Justino A; Parente B
    Ann Oncol; 2013 Aug; 24(8):2147-50. PubMed ID: 23585512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.